NDC 10122-550 – Mycapssa
Octreotide 20 mg/1 · Capsule, Delayed Release · Oral
Product NDC10122-550
Product details
- Brand name
- Mycapssa
- Generic name
- Octreotide
- Labeler
- Chiesi USA, Inc.
- Dosage form
- Capsule, Delayed Release
- Route
- Oral
- Marketing category
- NDA · NDA208232
- Marketed since
- July 6, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Somatostatin Analog
Active ingredients
- Octreotide 20 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 10122-550-28 | 4 BLISTER PACK in 1 DOSE PACK (10122-550-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK | Jul 6, 2020 |
Other Mycapssa products
- 69880-120 Octreotide 20 mg/1 · Capsule, Delayed Release · Amryt Pharmaceuticals Designated Activity Company